CDEK
← All drugs Report issue

pamiparib

Small moleculeexperimental

Clinical trial activity

32 trials · 35 clinical orgs · 0 marketing orgs

Phase 1
14
Phase 2
22
Phase 3
3
Phase 4
0

Earliest trial started Jul 1, 2014 (NCT02361723)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2018

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

C[C@]12CCCN1CC1=NNC(=O)c3cc(F)cc4[nH]c2c1c34
Mol. weight
298.32 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • bgb-290
  • bgb-290

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06692491Phase 2Jan 1, 2025Peking University
NCT06387056Phase 2Apr 1, 2024Xiamen University
NCT05669768Phase 2Jan 1, 2023Sun Yat-Sen University
NCT05573373Phase 1Dec 20, 2022Jiangnan University
NCT05652283Phase 2Nov 6, 2022Anhui Medical University
NCT05526924Phase 1Nov 1, 2022University of Chicago
NCT05489926Phase 2Aug 16, 2022Chinese Academy of Medical Sciences
NCT05494580Phase 1/Phase 2 (Phase 2)Aug 10, 2022Sun Yat-Sen University, University of Washington
NCT05483543Phase 2Jun 20, 2022Fudan University
NCT05327621Phase 2May 1, 2022Sun Yat-Sen University
NCT05376722Phase 2Feb 22, 2022Nanjing Medical University, Nanjing University, Soochow University, Zhejiang University
NCT05044871Phase 2Jan 1, 2022Anhui Medical University, Central South University, Chinese Academy of Medical Sciences, Huazhong University of Science and Technology, Jiangnan University, Jilin Provincial Tumor Hospital, Shandong University, Sun Yat-Sen University, Wuhan University, Zhejiang University
NCT05038839Phase 1Dec 30, 2021University of Texas at Houston
NCT04796454Phase 2Sep 30, 2021European Organisation for Research and Treatment of Cancer
NCT04985721Phase 2Aug 1, 2021Peter MacCallum Cancer Centre
NCT04603365Phase 2Jan 1, 2021BeOne Medicines, Driven To Cure, University of California, Los Angeles
NCT04614909Early Phase 1 (Phase 1)Dec 31, 2020Barrow Neurological Institute, BeOne Medicines, Ivy Brain Tumor Center, University of Arizona
NCT04164199Phase 3Dec 16, 2019BeOne Medicines
NCT03991494Phase 1Jun 30, 2019BeOne Medicines
NCT03914742Phase 1/Phase 2 (Phase 2)Jun 30, 2019BeOne Medicines, Johns Hopkins University, National Cancer Institute (NCI), University of Virginia, Yale University
Showing 20 of 32 trials
Page 1 / 2

Organizations

Research & Development (35)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
BeOne MedicinesFor profit161232014
Sun Yat-Sen UniversityAcademic/Hospital4312022
Myrexis Inc.For profit3022014
Anhui Medical UniversityAcademic/Hospital2112022
Chinese Academy of Medical SciencesAcademic/Hospital2112022
Jiangnan UniversityAcademic/Hospital2122022
Peter MacCallum Cancer CentreAcademic/Hospital2112019
Zhejiang UniversityAcademic/Hospital2012022
Australia New Zealand Gynaecological Oncology GroupAcademic/Hospital1112019
Barrow Neurological InstituteAcademic/Hospital1112020
Central South UniversityAcademic/Hospital1012022
Driven To CureAcademic/Hospital1012021
European Organisation for Research and Treatment of CancerAcademic/Hospital1112021
Fudan UniversityAcademic/Hospital1112022
Huazhong University of Science and TechnologyAcademic/Hospital1112022
Ivy Brain Tumor CenterAcademic/Hospital1012020
Jilin Provincial Tumor HospitalAcademic/Hospital1012022
Johns Hopkins UniversityAcademic/Hospital1112019
Nanjing Medical UniversityAcademic/Hospital1012022
Nanjing UniversityAcademic/Hospital1112022
35 organizations
Page 1 / 2